D2C personal care brand Antithesis raises ₹5 cr in pre-seed funding co-led by Rukam Capital, V3 Ventures

The investment will focus on product innovation, market expansion, and building the brand’s presence in India.

featured-image

D2C personal care brand Antithesis has raised ₹5 crore in a pre-seed funding round co-led by Rukam Capital and V3 Ventures. The investment comes when India’s beauty and personal care market is projected to reach $30 billion by 2027, driven by increasing consumer demand for high-performance, multifunctional products. The funding will be utilised for product innovation, expanding market and distribution channels, and strengthening the company’s presence in India while supporting brand building, hiring key team members, R&D, and the development of new SKUs.

Aparna Saxena, CEO & Founder of Antithesis, said, “The company plans to expand its product portfolio and retail presence while exploring global markets that align with its minimalist beauty philosophy.” Founded in 2018 by Aparna Saxena, previously a Partner at a VC fund, it aims to simplify personal care by challenging the multi-product approach. Comments.